combating allergy and asthma in europe: issues and perspectives. erika von mutius md msc professor...
TRANSCRIPT
![Page 1: Combating Allergy and Asthma in Europe: Issues and Perspectives. Erika von Mutius MD MSc Professor of Pediatrics University Childrens Hospital Munich,](https://reader036.vdocuments.us/reader036/viewer/2022062417/55152b3a550346c77d8b5655/html5/thumbnails/1.jpg)
Combating Allergy and Asthma in
Europe: Issues and Perspectives.
Erika von Mutius MD MSc
Professor of PediatricsUniversity Children‘s Hospital
Munich, Germany
![Page 2: Combating Allergy and Asthma in Europe: Issues and Perspectives. Erika von Mutius MD MSc Professor of Pediatrics University Childrens Hospital Munich,](https://reader036.vdocuments.us/reader036/viewer/2022062417/55152b3a550346c77d8b5655/html5/thumbnails/2.jpg)
WROCŁAW
![Page 3: Combating Allergy and Asthma in Europe: Issues and Perspectives. Erika von Mutius MD MSc Professor of Pediatrics University Childrens Hospital Munich,](https://reader036.vdocuments.us/reader036/viewer/2022062417/55152b3a550346c77d8b5655/html5/thumbnails/3.jpg)
0
10
20
30
40
5-10 11-20 21-30 31-40 41-50 51-60 61+
age
%
Sobotka
villages
lowest prevalencein Europe
UK-type prevalence
Atopic sensitisation in Sobotka and surrounding villages.
Sozanska et al, Allergy 2007
![Page 4: Combating Allergy and Asthma in Europe: Issues and Perspectives. Erika von Mutius MD MSc Professor of Pediatrics University Childrens Hospital Munich,](https://reader036.vdocuments.us/reader036/viewer/2022062417/55152b3a550346c77d8b5655/html5/thumbnails/4.jpg)
Lifetime residence and atopy.
0
5
10
15
20
25
30
35
5-20 yrs 21-40 yrs 41-60 yrs
Never village
Moved between townand village
Always village
Sozanska et al, Allergy 2007
![Page 5: Combating Allergy and Asthma in Europe: Issues and Perspectives. Erika von Mutius MD MSc Professor of Pediatrics University Childrens Hospital Munich,](https://reader036.vdocuments.us/reader036/viewer/2022062417/55152b3a550346c77d8b5655/html5/thumbnails/5.jpg)
Prevalence of atopy in Karelian children.
0
5
10
15
20
25
30
35
40
45
Asthma Hay fever Skin testpositive
Finnish
Russian
z
von Hertzen et al, JACI 2006
%
![Page 6: Combating Allergy and Asthma in Europe: Issues and Perspectives. Erika von Mutius MD MSc Professor of Pediatrics University Childrens Hospital Munich,](https://reader036.vdocuments.us/reader036/viewer/2022062417/55152b3a550346c77d8b5655/html5/thumbnails/6.jpg)
Pakarinen et al, Environ Microbiology 2008
Microbial exposures
in Finnish and Russian
Karelian homes.
![Page 7: Combating Allergy and Asthma in Europe: Issues and Perspectives. Erika von Mutius MD MSc Professor of Pediatrics University Childrens Hospital Munich,](https://reader036.vdocuments.us/reader036/viewer/2022062417/55152b3a550346c77d8b5655/html5/thumbnails/7.jpg)
Allergy protection from exposures to stables,
farm milk and barns (ALEX Study).
0
0,1
0,2
0,3
0,4
0,5
0,6
0,7
0,8
0,9
1
Asthma Wheeze Hay feverdiagnosis
Hay feversymptoms
Atopy
No exposureOne exposureAt least 2 exposuresAll 3 exposures
OR
![Page 8: Combating Allergy and Asthma in Europe: Issues and Perspectives. Erika von Mutius MD MSc Professor of Pediatrics University Childrens Hospital Munich,](https://reader036.vdocuments.us/reader036/viewer/2022062417/55152b3a550346c77d8b5655/html5/thumbnails/8.jpg)
DNAextraction
denaturationof DNA
amplificationof the bacterial16S rRNA gene
ds DNA
exonucleasedigestion
ss DNA
statistical analysis for significantassociations with health outcomes
or farm-related exposuresscanning gel and
transformation intodensity values
mattressdust
gel-electrophoresis
under non-denaturing conditions
![Page 9: Combating Allergy and Asthma in Europe: Issues and Perspectives. Erika von Mutius MD MSc Professor of Pediatrics University Childrens Hospital Munich,](https://reader036.vdocuments.us/reader036/viewer/2022062417/55152b3a550346c77d8b5655/html5/thumbnails/9.jpg)
Study the Microbiome in Environmental Samples by Pyrosequencing.
• The ‚New Age of Molecular Diagnostics for Microbial Agents‘ (R. Whitley in NEJM March 2008).
• The most comprehensive
method to detect bacteria, viruses, fungi of all known and unknown species.
• Will identify the most solid, so far unexplored, candidates.
Margulies et al, Nature 2005; Whitley NEJM 2008, Palacios et al, NEJM 2008.
![Page 10: Combating Allergy and Asthma in Europe: Issues and Perspectives. Erika von Mutius MD MSc Professor of Pediatrics University Childrens Hospital Munich,](https://reader036.vdocuments.us/reader036/viewer/2022062417/55152b3a550346c77d8b5655/html5/thumbnails/10.jpg)
Children 6-12 years Alpine regions and
PolandParental questionnaire
Blood sampling:Allergy test, DNA/RNA
Indoor and outdoor dust
Milk samples
Phenotypes
Population
Exposure
Genetics
Nasal and throat swabs
Lung function
GABRIEL Advanced Surveys
![Page 11: Combating Allergy and Asthma in Europe: Issues and Perspectives. Erika von Mutius MD MSc Professor of Pediatrics University Childrens Hospital Munich,](https://reader036.vdocuments.us/reader036/viewer/2022062417/55152b3a550346c77d8b5655/html5/thumbnails/11.jpg)
GABRIEL Advanced Survey Design
• Stage I: Recruitment in alpine areas– Recruitment questionnaire to large populations (N=135,359).
Participation rate: 80.7%. • Randomisation: Random sample of full consent group
• Stage II: Main study– Comprehensive questionnaire, blood samples (IgE, genetics),
dust samples, nasal swabs (n=9,668)• Randomisation: Random sample in area with strongest effects
(Germany)
• Stage III: In depth environmental exposure– Collection of multiple dust samples, milk samples, throat swabs
and measurement of lung function (n=895)
![Page 12: Combating Allergy and Asthma in Europe: Issues and Perspectives. Erika von Mutius MD MSc Professor of Pediatrics University Childrens Hospital Munich,](https://reader036.vdocuments.us/reader036/viewer/2022062417/55152b3a550346c77d8b5655/html5/thumbnails/12.jpg)
GABRIEL exposure assessment.
• Because of restricted funding only possible in 225 subjects (26.2% of subjects in Stage III)– Bacterial exposure by 16 sRNA– Viable bacteria– Endotoxin– Muramic acid– CpG DNA– Fungal exposure by 16 sRNA
![Page 13: Combating Allergy and Asthma in Europe: Issues and Perspectives. Erika von Mutius MD MSc Professor of Pediatrics University Childrens Hospital Munich,](https://reader036.vdocuments.us/reader036/viewer/2022062417/55152b3a550346c77d8b5655/html5/thumbnails/13.jpg)
Vision for FP7:
• Comprehensive characterisation of allergy protective environments (Alpine Areas, Eastern Europe, China).
• Test identified allergy protective microbes / compounds in experimental studies.
• Develop novel prevention strategies